Evidence map›Paper›PMID 29988482›Full record

ArticleFrontiers in chemistry2018

Effective

Álvaro Artiga, Sonia García-Embid, Laura De Matteis, Scott G Mitchell, Jesús M de la Fuente

Abstract read
In one paragraph

Article in Frontiers in chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. FePharmaceutics · 2021
    Article
  5. An approach to the photocatalytic mechanism in the TiOApplied catalysis. B, Environmental · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Álvaro ArtigaInstituto de Ciencia de Materiales de Aragón, Consejo Superior de Investigaciones Científicas, Universidad de Zaragoza and CIBER-BBN, Zaragoza, Spain.
Sonia García-EmbidInstituto de Ciencia de Materiales de Aragón, Consejo Superior de Investigaciones Científicas, Universidad de Zaragoza and CIBER-BBN, Zaragoza, Spain.
Laura De MatteisInstituto de Nanociencia de Aragón, Universidad de Zaragoza and CIBER-BBN, Zaragoza, Spain.
Scott G MitchellInstituto de Ciencia de Materiales de Aragón, Consejo Superior de Investigaciones Científicas, Universidad de Zaragoza and CIBER-BBN, Zaragoza, Spain.
Jesús M de la FuenteInstituto de Ciencia de Materiales de Aragón, Consejo Superior de Investigaciones Científicas, Universidad de Zaragoza and CIBER-BBN, Zaragoza, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Upon excitation of their localized surface plasmon resonance (LSPR) band, gold nanorods (AuNRs) show a characteristic light-to-heat transduction, a useful and versatile property for a range of biomedical applications such as photothermal therapy, drug delivery, optoacoustic imaging and biosensing, among others. Nanoparticle (NP)-mediated photothermal therapy (PTT) rests on the ability of nanomaterials to convert light energy into heat and can currently be considered as a promising method for selectively destroying tumor cells by (photo)-thermoablation. One inherent limitation to NP-mediated PTT is that the nanoparticles must arrive at the site of action to exert their function and this typically involves cellular internalization. Here we report the use of the Keggin-type polyoxometalate (POM) phosphotungstic acid (PTA) as an inorganic gelling agent for the encapsulation of plasmonic gold nanorods (AuNRs) inside a biocompatible and cell-adhesive chitosan hydrogel matrix. These functional sub-micrometric containers are non-cytotoxic and present the ability to adhere to the cytoplasmic membranes of cells avoiding any need for cellular internalization, rendering them as highly efficient thermoablating agents of eukaryotic cells

Indexed as

chitosan hydrogelencapsulationgold nanorodnear infra-redphotothermal therapypolyoxometalate

Identifiers

PMID29988482
PMCPMC6024193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.